London School of Hygiene and Tropical Medicine: Malaria, Falciparum trials

The registry lists 20 Malaria, Falciparum studies with London School of Hygiene and Tropical Medicine as lead sponsor. 1 are open to participants now and 2 have results posted.

Phase 2 5Phase 3 11Phase 4 3No phase 2(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Serological Testing and Treatment for Plasmodium Vivax Malaria: a Trial in Ethiopia and MadagascarRecruitingNCT06923592Phase 3
• Seasonal Malaria Vaccination (RTS,S/AS01) and Seasonal Malaria Chemoprevention (SP/AQ) Extension StudyCompletedNCT04319380Phase 3Results posted
• Seasonal Malaria Vaccination (RTS,S/AS01) and Seasonal Malaria Chemoprevention (SP/AQ)CompletedNCT03143218Phase 3Results posted
• Understanding and Maximizing the Community Impact of Antimalarial Treatment (INDIE-SMC)CompletedNCT05878366Not applicable
• Gametocytocidal and Transmission-blocking Efficacy of ASAQ and ALAQ With or Without PQ in MaliCompletedNCT05550909Phase 2
• Vectron T500 (Broflanilide 50WP) for IRS in Tanzania TanzaniaStatus unknownNCT05150808Phase 3
• Gametocytocidal and Transmission-blocking Efficacy of PQ in Combination With AL and TQ in Combination With SPAQ in MaliCompletedNCT05081089Phase 2
• Adjunctive Ivermectin Mass Drug Administration for Malaria ControlStatus unknownNCT04844905Phase 3
• Single Low Dose Tafenoquine to Reduce P. Falciparum Transmission in Mali (NECTAR2)CompletedNCT04609098Phase 2
• Pyronaridine-artesunate With Low Dose Primaquine for Preventing P. Falciparum TransmissionCompletedNCT04049916Phase 2/3
• Artemisinin-based Combination Therapy for Treatment of Plasmodium Falciparum Malaria in North Sumatera, IndonesiaCompletedNCT02325180Phase 4
• Impact of Insecticide Resistance on Vector ControlStatus unknownNCT01713517Phase 4
• Evaluation of the Gametocytocidal Efficacy and Safety of Primaquine in Uncomplicated Falciparum Malaria in UgandaCompletedNCT01365598Phase 3
• Extended-dose Chloroquine (ECQ) for Resistant Falciparum Malaria Among Afghan Refugees in PakistanCompletedNCT01019408Phase 4
• Trial of Artesunate Combination Therapy in PakistanCompletedNCT00959517Phase 2
• Tolerability and Efficacy of CD+A Compared to AQ+SP for the Treatment of P.Falciparum Malaria in Rwandan ChildrenCompletedNCT00461578Not applicable
• Effect of Antimalarial Treatment on Gametocyte Carriage in Asymptomatic P. FalciparumCompletedNCT00289250Phase 3
• ACT With Chloroquine, Amodiaquine & Sulphadoxine-pyrimethamine in PakistanCompletedNCT00158548Phase 3
• Study of the Impact of Intermittent Preventive Treatment in Schools on Malaria, Anaemia and Education.CompletedNCT00142246Phase 3
• Preventing Malaria During Pregnancy in Epidemic-prone Areas.CompletedNCT00142207Phase 3